Supplementary Table 1 contains the patient characteristics of the data sets. NEAT1’s expression ranked in the 99th percentile of all genes on the microarray (Fig. 2b). We determined levels of NEAT1 by RNA in situ hybridization (ISH) in a tissue microarray that included 16 benign prostate tissues, 21 PCa, 12 PCa with neuroendocrine differentiation and 7 NEPC cases. NEAT1 was found to be highly expressed in prostate cancer compared with that in benign tissue (Supplementary Fig. 2b). The gene discussed is NEAT1; the disease is posterior cortical atrophy.